The common germline Arg72Pro polymorphism of p53 and increased longevity in humans

被引:76
作者
Bojesen, Stig E.
Nordestgaard, Borge G.
机构
[1] Univ Copenhagen, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark
[2] Univ Copenhagen Hosp, Herlev, Denmark
关键词
longevity; ageing; mortality; p53; Arg72Pro; SNP; polymorphism; cancer risk;
D O I
10.4161/cc.7.2.5249
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
More than ten million single nucleotide polymorphisms ( SNPs) have been identified in humans; however, the importance of most SNPs for health and disease is not understood. Most SNPs are indeed unimportant and because of often inadequately powered studies, many observations on SNP effects can not be repeated by other researchers. SNPs are at best shown to influence protein function or level, rarely to influence risk of disease, and almost never to influence total mortality, the ultimate endpoint. A well-known functional SNP in the tumor suppressor TP53 gene leads to increased longevity: in the Danish general population (n = 9219) homozygotes for the minor allele versus homozygotes for the major allele had an increase in median survival of 3 years. This is partly explained by increased survival after development of cancer or other diseases, in accordance with the observation that this Arg72Pro substitution in the p53 protein has important influence on cell death via increased apoptosis. Thus, the increased longevity may be due to a generally increased robustness after a diagnosis of any life-threatening disease. In contrast to widespread skepticism on the importance of SNPs in humans, this gain-of-function p53 SNP of importance for cell repair mechanisms has a profound influence on longevity.
引用
收藏
页码:158 / 163
页数:6
相关论文
共 47 条
[1]
A haplotype map of the human genome [J].
Altshuler, D ;
Brooks, LD ;
Chakravarti, A ;
Collins, FS ;
Daly, MJ ;
Donnelly, P ;
Gibbs, RA ;
Belmont, JW ;
Boudreau, A ;
Leal, SM ;
Hardenbol, P ;
Pasternak, S ;
Wheeler, DA ;
Willis, TD ;
Yu, FL ;
Yang, HM ;
Zeng, CQ ;
Gao, Y ;
Hu, HR ;
Hu, WT ;
Li, CH ;
Lin, W ;
Liu, SQ ;
Pan, H ;
Tang, XL ;
Wang, J ;
Wang, W ;
Yu, J ;
Zhang, B ;
Zhang, QR ;
Zhao, HB ;
Zhao, H ;
Zhou, J ;
Gabriel, SB ;
Barry, R ;
Blumenstiel, B ;
Camargo, A ;
Defelice, M ;
Faggart, M ;
Goyette, M ;
Gupta, S ;
Moore, J ;
Nguyen, H ;
Onofrio, RC ;
Parkin, M ;
Roy, J ;
Stahl, E ;
Winchester, E ;
Ziaugra, L ;
Shen, Y .
NATURE, 2005, 437 (7063) :1299-1320
[2]
Bastiaens MT, 2001, MOL CARCINOGEN, V30, P56, DOI 10.1002/1098-2744(200101)30:1<56::AID-MC1013>3.0.CO
[3]
2-2
[4]
IS P53 POLYMORPHISM MAINTAINED BY NATURAL-SELECTION [J].
BECKMAN, G ;
BIRGANDER, R ;
SJALANDER, A ;
SAHA, N ;
HOLMBERG, PA ;
KIVELA, A ;
BECKMAN, L .
HUMAN HEREDITY, 1994, 44 (05) :266-270
[5]
iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72 polymorphic p53 [J].
Bergamaschi, Daniele ;
Samuels, Yardena ;
Sullivan, Alexandra ;
Zvelebil, Marketa ;
Breyssens, Hilde ;
Bisso, Andrea ;
Del Sal, Giannino ;
Syed, Nelofer ;
Smith, Paul ;
Gasco, Milena ;
Crook, Tim ;
Lu, Xin .
NATURE GENETICS, 2006, 38 (10) :1133-1141
[6]
Effect of p53 alleles on placental weight [J].
Birgander, R ;
Sjalander, A ;
Beckman, G ;
Beckman, L .
HUMAN HEREDITY, 1996, 46 (05) :290-297
[7]
Integrin β3 Leu33Pro homozygosity and risk of cancer [J].
Bojesen, SE ;
Tybjærg-Hansen, A ;
Nordestgaard, BG .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (15) :1150-1157
[8]
Fragile fugue: p53 in aging, cancer and IGF signaling [J].
Campisi, J .
NATURE MEDICINE, 2004, 10 (03) :231-232
[9]
Cancer and ageing: Rival demons? [J].
Campisi, J .
NATURE REVIEWS CANCER, 2003, 3 (05) :339-349
[10]
Senescent cells, tumor suppression, and organismal aging: Good citizens, bad neighbors [J].
Campisi, J .
CELL, 2005, 120 (04) :513-522